SCHEMBL6470903

SCHEMBL6470903

CCCCOc1cccc2nc(Nc3nc(C)c4cc(OC)c(OC)cc4n3)nc(O)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
TP53 P04637 4/20 0.40
NPSR1 Q6W5P4 1/20 0.39
POLB P06746 2/20 0.39
RAD52 P43351 1/20 0.39
EGFR P00533 4/20 0.38
KDR P35968 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
FGFR1 P11362 1/20 0.38
FLT1 P17948 1/20 0.38
SRC P12931 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38
RET P07949 2/20 0.38
SLC2A1 P11166 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470260 0.91 TP53 (0.42) MAPTTP53NPSR1POLBRAD52
Trifluoroacetic Acid SCHEMBL6470334 0.80 ABCG2 (0.42) MAPTTP53POLBRAD52MEN1
Acetic Acid SCHEMBL6469268 0.79 SMN1; SMN2 (0.42) MAPTTP53NPSR1POLBRAD52
SCHEMBL6467464 0.78 ADORA2B (0.43) MAPTTP53NPSR1POLBRAD52
SCHEMBL6470113 0.78 MAPT (0.51) MAPTTP53NPSR1POLBRAD52
SCHEMBL6469370 0.77 ABCG2 (0.44) MAPTTP53NPSR1POLBRAD52
SCHEMBL6465723 0.76 TP53 (0.45) MAPTTP53POLBRAD52EGFR
Trifluoroacetic Acid SCHEMBL6467192 0.76 WHR1 (0.41) MAPTTP53POLBRAD52MEN1
Hydrochloric Acid SCHEMBL6470480 0.76 SLC2A1 (0.45) MAPTTP53NPSR1POLBRAD52
Trifluoroacetic Acid SCHEMBL6469755 0.74 KMT2A (0.40) MAPTTP53NPSR1POLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB MAPT 3552/4885TP53 1339/4885NPSR1 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.